Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
about
Use of antipsychotics in the treatment of depressive disordersBeyond obesity and lifestyle: a review of 21st century chronic disease determinantsRNA sequencing reveals a slow to fast muscle fiber type transition after olanzapine infusion in ratsEffect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT2) in Sprague-Dawley rats.Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Obesity and cognitive decline: role of inflammation and vascular changes.Excess risk of chronic physical conditions associated with depression and anxietyEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Effect of comedication of bupropion and other antidepressants on body mass index.Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/dThe diagnosis and treatment of generalized anxiety disorder.Obesity-associated oxidative stress: strategies finalized to improve redox state.The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depressionMetabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder.Weight considerations in psychotropic drug prescribing and switching.Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.Weight gain and antipsychotics: a drug safety review.The Effect of Medical Marijuana Laws on Body Weight.Isolated sinus tachycardia following reinitiation of risperidone in a patient with suspected autonomic hypersensitivity.Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in mice.The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study.
P2860
Q26860391-BAA850AE-FEC1-40D6-B811-C12C22DCF36CQ27021925-9829CF7F-287C-4BFD-9F7C-3DF65A62BC2BQ27309270-C6BC4F89-EAE0-40AF-8271-1E0958DCF232Q33744440-F87185C8-E477-4A01-ACB7-2B27B4DC5197Q34000520-8B8F4165-0804-4713-993E-E0DE6471BEC0Q34243328-E542C99D-A86A-4EEB-937E-E6A75D3AABC7Q34540572-4ACFFBD4-9732-4703-AA83-7589DE363D4DQ35085378-15200000-0BF1-4134-9EAF-1FA43D80110EQ35754726-160CDA6B-779C-48C4-9C4B-8BCB7D4B0930Q35852531-ABF17797-D5BF-4D04-8B2E-BEDB4BB58A1FQ36065939-1B458D58-F7BA-414B-9308-CDEA4CAB5909Q36083244-FACBC698-6560-42DC-B65F-3B75ACD76CB3Q36837462-ABF553DA-D918-4067-8532-576B4D7C20CCQ36913776-B1324F31-9FDE-4A6F-B192-F4541844107BQ37187659-E3CE2A70-AC82-40AF-AD6D-6E81A1BAC971Q37397705-F4F08AAF-87B0-4A94-933E-7EFC366362B7Q38151453-64C3A587-DE98-47D3-B974-E3A1902CE491Q38151984-68341AB2-2BE6-4241-8306-D1AB339F79C1Q38268590-A27A260E-1C7D-44F9-9D8F-1D302EE5047DQ40280337-8A060334-8E33-4720-9634-514B0B7455A7Q42085292-CA549AAD-B54A-445F-BC18-C4E60EA5700CQ47649889-7789D0B2-725D-4579-8153-2F86E97C9776Q47812207-AAE4140E-2792-41A0-AB90-1AF203C55D62
P2860
Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Weight gain and glucose dysreg ...... w for primary care physicians.
@ast
Weight gain and glucose dysreg ...... w for primary care physicians.
@en
Weight gain and glucose dysreg ...... w for primary care physicians.
@nl
type
label
Weight gain and glucose dysreg ...... w for primary care physicians.
@ast
Weight gain and glucose dysreg ...... w for primary care physicians.
@en
Weight gain and glucose dysreg ...... w for primary care physicians.
@nl
prefLabel
Weight gain and glucose dysreg ...... w for primary care physicians.
@ast
Weight gain and glucose dysreg ...... w for primary care physicians.
@en
Weight gain and glucose dysreg ...... w for primary care physicians.
@nl
P2093
P2860
P921
P356
P1476
Weight gain and glucose dysreg ...... w for primary care physicians.
@en
P2093
Bruce Hollett
Mehrul Hasnain
W Victor R Vieweg
P2860
P304
P356
10.3810/PGM.2012.07.2577
P407
P577
2012-07-01T00:00:00Z